US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Spirit Realty Capital

42.31

+0.0000

Volume:- -

Turnover:- -

Market Cap:5.99B

PE:24.03

High:42.31

Open:42.31

Low:42.31

Close:42.31

Loading ...

Overview Company News Filings

TransCode Therapeutics Announces First Patient Dosed in Third Cohort with Lead Candidate in Phase 1 Clinical Trial

Health Check: Which stock just dumped 19% on earnings downgrade?

Island Pharmaceuticals starts phase 2b dengue trial

CAMP4 Provides Corporate Updates and Highlights Key Upcoming Milestones

TransCode Therapeutics Announces Safety Review Committee Approval of Opening Third Cohort and Preliminary Results from First Cohort in Phase 1 TTX-MC138 Clinical Trial

Shops being ‘thwacked by colossal’ employment costs

Silvaco Joins SMART USA Institute to Propel Digital Twin Innovations Under CHIPS Manufacturing USA Program

ASX Lunch Wrap: ASX a sea of green after ceasefire; Island Pharma up 30pc on trial results

Here's why this ASX pharmaceutical stock just rocketed 70%

Tryptamine’s world-first psilocin based IV-infusion meets key objectives in phase 1b study

Pasithea Therapeutics announces SRC recommended proceeding to cohort 4

Pasithea Therapeutics Announces Positive Safety Review Committee (SRC) Recommendation from its ongoing Phase 1 Clinical Trial of PAS-004 in Advanced Cancer

Deutsche Bank Reaffirms Their Buy Rating on SigmaRoc (SRC)

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/SRC/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"SRC","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SRC\",,,,,undefined,":{"symbol":"SRC","market":"US","secType":"STK","nameCN":"Spirit Realty Capital","latestPrice":42.31,"timestamp":1746648000000,"preClose":42.31,"halted":0,"volume":0,"delay":0,"floatShares":140027263,"shares":141552606,"eps":1.76103,"marketStatus":"Pre-Mkt","change":0,"latestTime":"05-08 08:44:29 EDT","open":42.31,"high":42.31,"low":42.31,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":1.76103,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1746711000000},"marketStatusCode":1,"adr":0,"adrRate":0,"listingDate":1348113600000,"exchange":"NYSE","adjPreClose":42.31,"dividendRate":0.062836,"volumeRatio":4.416625630369353,"impliedVol":0.3737,"impliedVolPercentile":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SRC\",,,,,undefined,":{"symbol":"SRC","floatShares":140027263,"roa":"2.42%","roe":"5.74%","lyrEps":2.040987,"volumeRatio":4.416625630369353,"shares":141552606,"dividePrice":2.6586,"high":42.31,"amplitude":0,"preClose":42.31,"low":42.31,"week52Low":42.31,"pbRate":"1.38","psRate":"7.94","week52High":42.31,"institutionHeld":0,"latestPrice":42.31,"eps":1.76103,"divideRate":0.062836,"volume":0,"delay":0,"ttmEps":1.76103,"open":42.31,"prevYearClose":42.31,"prevWeekClose":42.31,"prevMonthClose":42.31,"prevQuarterClose":42.31,"fiveDayClose":42.31,"twentyDayClose":42.31,"sixtyDayClose":42.31},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"SRC\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2503520577","title":"TransCode Therapeutics Announces First Patient Dosed in Third Cohort with Lead Candidate in Phase 1 Clinical Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2503520577","media":"PR Newswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503520577?lang=en_us&edition=fundamental","pubTime":"2025-01-14 21:00","pubTimestamp":1736859600,"startTime":"0","endTime":"0","summary":"Follows Safety Review Committee  approval based on safety data from patients in Cohorts 1 and 2. No significant safety or dose limitingtoxicities reported in Cohorts 1 and 2. BOSTON, Jan. 14, 2025 /PRNewswire/ -- TransCode Therapeutics, Inc. , the RNA oncology company committed to more effectively treating cancer using RNA therapeutics, today announced that the first patient in Cohort 3 of its Phase 1 clinical trial has been dosed with TTX-MC138, its lead candidate. The Safety Review Committee monitoring the clinical trial unanimously approved opening of the third cohort based on its favorable review of Cohort 1 and 2 safety and pharmacokinetic  data.Additional Cohort 3 patients have been scheduled. The dose administered to patients in the third cohort is approximately double the dose administered to those in the second cohort.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/transcode-therapeutics-announces-first-patient-130000158.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/transcode-therapeutics-announces-first-patient-130000158.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU1169590202.USD","BK4023","LU1169589451.USD","RNAZ","BK4139","PK","BK4231","SRC","LENZ","BK4539","PD","BK4080","BK4218","BK4181"],"gpt_icon":0},{"id":"2501876771","title":"Health Check: Which stock just dumped 19% on earnings downgrade?","url":"https://stock-news.laohu8.com/highlight/detail?id=2501876771","media":"Stockheads","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2501876771?lang=en_us&edition=fundamental","pubTime":"2025-01-08 11:36","pubTimestamp":1736307399,"startTime":"0","endTime":"0","summary":"Wound care company Avita Medical slumps ~19% on downgrade of its earnings guidance. 2024, Next Science LLC started legal against Mr Morello and several former employees for breach of post-employment restraints .Next Science is headquartered in Sydney with a research and development centre in Florida, USA. The company’s primary focus is on its proprietary XBIO technology to reduce the impact of biofilm-based infections in human health.“Mr Morello’s complaint makes several claims including that Next Science’s XBIOTM technology has not been approved by the FDA as a biofilm eradication process and that the company did not take adequate measures to address safety concerns about the use of its surgical solution XPERIENCE in breast implant procedures,” the company said in an announcement.Next Science said it confirms that the","market":"us","thumbnail":"https://stockhead.com.au/wp-content/uploads/2025/01/1200x675-1-640x360.jpg","type":0,"news_type":0,"thumbnails":["https://stockhead.com.au/wp-content/uploads/2025/01/1200x675-1-640x360.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stockhead.com.au/health/health-check-which-stock-just-dumped-19-on-earnings-downgrade/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockheads_stock","symbols":["BK4231","BK4080","SRC"],"gpt_icon":0},{"id":"2501886761","title":"Island Pharmaceuticals starts phase 2b dengue trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2501886761","media":"Stockheads","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2501886761?lang=en_us&edition=fundamental","pubTime":"2025-01-08 10:31","pubTimestamp":1736303469,"startTime":"0","endTime":"0","summary":"Island Pharmaceuticals commences phase 2b clinical trial of ISLA-101 in dengue fever. Progression to phase 2b cohort follows recommendation of the Safety Review Committee. High-level results from the phase 2b study are anticipated to be available around April 2025","market":"hk","thumbnail":"https://stockhead.com.au/wp-content/uploads/2025/01/2025-1-8-ILA-NM-640x360.jpg","type":0,"news_type":0,"thumbnails":["https://stockhead.com.au/wp-content/uploads/2025/01/2025-1-8-ILA-NM-640x360.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stockhead.com.au/health/island-pharmaceuticals-starts-phase-2b-dengue-trial/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockheads_stock","symbols":["SRC","BK4231","BK4080"],"gpt_icon":0},{"id":"2501302557","title":"CAMP4 Provides Corporate Updates and Highlights Key Upcoming Milestones","url":"https://stock-news.laohu8.com/highlight/detail?id=2501302557","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2501302557?lang=en_us&edition=fundamental","pubTime":"2025-01-08 05:05","pubTimestamp":1736283900,"startTime":"0","endTime":"0","summary":"Data from Single Ascending Dose (SAD) portion of Phase 1 study of CMP-CPS-001 for the treatment of urea cycle disorders (UCDs) demonstrates favorable safety resultsCompleted dosing in the first two Mu","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/01/07/3005832/0/en/CAMP4-Provides-Corporate-Updates-and-Highlights-Key-Upcoming-Milestones.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4231","ASO","BK4023","BK4200","BK4080","LU1169589451.USD","LU1169590202.USD","PD","BK4561","SRC"],"gpt_icon":0},{"id":"2492987185","title":"TransCode Therapeutics Announces Safety Review Committee Approval of Opening Third Cohort and Preliminary Results from First Cohort in Phase 1 TTX-MC138 Clinical Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2492987185","media":"PR Newswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492987185?lang=en_us&edition=fundamental","pubTime":"2024-12-18 21:00","pubTimestamp":1734526800,"startTime":"0","endTime":"0","summary":"Approval given after Safety Review Committee  review of safety data from the three patients comprising Cohort 2. No significant safety or dose limiting toxicities reported in Cohort 2. New patients currently being evaluated for eligibility in Cohort 3. \"An SRC is a group of clinicians andexperts that oversee patient safety during the conduct of a clinical trial. The SRC determines whether and how a study should proceed, including dose escalation and de-escalation decisions in accordance with the study design.The recommendations of the SRC are used to decide whether a clinical trial should be continued as designed, changed, or terminated,\" commented Sue Duggan, TransCode's Senior Vice President of Operations. Duggan added, \"Enrollment into the study continues based on the cumulative safety data review. Eligible patients may now be screened and scheduled in Cohort 3 for treatment with the next dose level of TTX-MC138 while preliminary data analysis continues.\". TTX-MC138 is a first-in-cl","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/b8NZzcjHfmcg8LoClKaRIA--~B/aD00MDA7dz0zODg7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/fe631664da71af51b3efd404fa58537e","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/b8NZzcjHfmcg8LoClKaRIA--~B/aD00MDA7dz0zODg7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/fe631664da71af51b3efd404fa58537e"],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/transcode-therapeutics-announces-safety-review-130000606.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/transcode-therapeutics-announces-safety-review-130000606.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4080","PK","BK4231","PD","BK4181","SRC","LU1169590202.USD","BK4218","BK4139","LENZ","RNAZ","BK4023","BK4539","LU1169589451.USD"],"gpt_icon":0},{"id":"2492889011","title":"Shops being ‘thwacked by colossal’ employment costs","url":"https://stock-news.laohu8.com/highlight/detail?id=2492889011","media":"cityam","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492889011?lang=en_us&edition=fundamental","pubTime":"2024-12-18 20:48","pubTimestamp":1734526105,"startTime":"0","endTime":"0","summary":"Shops in Scotland are facing a huge rise in costs when the new tax year starts.  Business rates rises totalling 7.6m are being faced by shops in Scotland when the new tax year starts, according to new figures.A total of 4,520 shops liable for the intermediate and higher property rates will experience an increase in their rates bills, according to information obtained by Conservative MSP Craig Hoy and published by the Scottish Retail Consortium .The SRC added these same stores saw their rates bills rise 31m in the current financial year.It comes after the Scottish Government announced the business rate for all firms occupying medium-sized and larger commercial premises will increase by 1.7 per cent in 2025-26.This will affect more than 22,000 businesses and marks the rate at a 26-year high, the SRC said.Around 2,380 stores are liable for the higher property rate and will pay a higher business rate than their English counterparts, for the 10th year in a row, it said.Hotels will see their","market":"fut","thumbnail":"https://www.cityam.com/wp-content/uploads/2024/12/GettyImages-1294459830-2.jpg?w=824&h=463&crop=1","type":0,"news_type":0,"thumbnails":["https://www.cityam.com/wp-content/uploads/2024/12/GettyImages-1294459830-2.jpg?w=824&h=463&crop=1"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.cityam.com/shops-being-thwacked-by-colossal-employment-costs/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"cityam_highlight","symbols":["BK4080","SRC","BK4231"],"gpt_icon":0},{"id":"2488193445","title":"Silvaco Joins SMART USA Institute to Propel Digital Twin Innovations Under CHIPS Manufacturing USA Program","url":"https://stock-news.laohu8.com/highlight/detail?id=2488193445","media":"Business Wire","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2488193445?lang=en_us&edition=fundamental","pubTime":"2024-12-04 21:00","pubTimestamp":1733317200,"startTime":"0","endTime":"0","summary":"SANTA CLARA, Calif., December 04, 2024----Silvaco Group, Inc. , a provider of TCAD, EDA software, and SIP solutions that enable semiconductor design and digital twin modeling through AI software and innovation, is proud to announce its participation in the Semiconductor Manufacturing and Advanced Research with Twins  USA Institute. This first-of-its-kind initiative, part of the CHIPS Manufacturing USA program under the CHIPS and Science Act, focuses on leveraging digital twin technologies to advance semiconductor design, manufacturing, and packaging.The Department of Commerce’s CHIPS for America program has entered into negotiations to provide Semiconductor Research Corporation Manufacturing Consortium Corporation  $285 million to establish and operate the SMART USA Institute. The SMART USA Institute, with more than 150 expected partner entities representing industry, academia and the full spectrum of supply chain design and manufacturing, will span more than 30 states and have combine","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/6TZqVX_qp9UR0v_r305kzA--~B/aD0zMDk7dz0xMjAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/c61f078b231fb64e6838b57395049217","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/6TZqVX_qp9UR0v_r305kzA--~B/aD0zMDk7dz0xMjAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/c61f078b231fb64e6838b57395049217"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/silvaco-joins-smart-usa-institute-130000250.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4231","BK4080","SVCO","BK4097","SRC"],"gpt_icon":0},{"id":"2486896616","title":"ASX Lunch Wrap: ASX a sea of green after ceasefire; Island Pharma up 30pc on trial results","url":"https://stock-news.laohu8.com/highlight/detail?id=2486896616","media":"Stockheads","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2486896616?lang=en_us&edition=fundamental","pubTime":"2024-11-27 11:22","pubTimestamp":1732677755,"startTime":"0","endTime":"0","summary":"ASX opens higher, boosted by Wall Street rally and ceasefire news. Bitcoin dips below $92,000, but regains mark shortly after. Web Travel jumps, Lynas up despite market concerns","market":"us","thumbnail":"https://stockhead.com.au/wp-content/uploads/2024/11/ASX-opens-higher-boosted-by-Wall-Street-rally-and-ceasefire-news.-Picture-via-Getty-Images-640x360.jpg","type":0,"news_type":0,"thumbnails":["https://stockhead.com.au/wp-content/uploads/2024/11/ASX-opens-higher-boosted-by-Wall-Street-rally-and-ceasefire-news.-Picture-via-Getty-Images-640x360.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stockhead.com.au/news/asx-lunch-wrap-asx-a-sea-of-green-after-ceasefire-island-pharma-up-30pc-on-trial-results/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockheads_stock","symbols":["BK4080","BK4231","PASS","SRC"],"gpt_icon":0},{"id":"2486857064","title":"Here's why this ASX pharmaceutical stock just rocketed 70%","url":"https://stock-news.laohu8.com/highlight/detail?id=2486857064","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2486857064?lang=en_us&edition=fundamental","pubTime":"2024-11-27 08:42","pubTimestamp":1732668178,"startTime":"0","endTime":"0","summary":"Island Pharmaceuticals Ltd  shares are catching the eye on Wednesday. In morning trade, the ASX pharmaceutical stock rocketed as much as 70% to a 52-week high of 28 cents. Why is this ASX pharmaceutical stock rocketing?","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com.au/2024/11/27/heres-why-this-asx-pharmaceutical-stock-just-rocketed-70/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["ILA.AU","BK7096","SRC","BK4231","BK4080"],"gpt_icon":0},{"id":"2485444079","title":"Tryptamine’s world-first psilocin based IV-infusion meets key objectives in phase 1b study","url":"https://stock-news.laohu8.com/highlight/detail?id=2485444079","media":"Stockheads","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2485444079?lang=en_us&edition=fundamental","pubTime":"2024-11-22 04:35","pubTimestamp":1732221305,"startTime":"0","endTime":"0","summary":"Tryptamine’s phase 1b study of IV-infused psilocin meets all objectives. Lead asset TRP-8803 found safe at low, mid and upper dose levels. Planning underway to advance TRP-8803 in phase II trials. Special Report: Clinical stage biotech Tryptamine Therapeutics has achieved a major milestone in the development of itsnovel IV-infused psilocin formulation TRP-8803, with all objectives of the phase 1b study met. Tryptamine Therapeutics has provided further data from its recently completed phase 1b study utilising TRP-8803, with all key objectives met including:. Optimal doses and infusion rates of psilocin achieved targeted psilocin blood levels. Greater control of psilocin blood levels achieved compared to oral psilocybin formulations","market":"us","thumbnail":"https://stockhead.com.au/wp-content/uploads/2024/11/2024-19-11-TYP-NM-1-640x360.jpg","type":0,"news_type":0,"thumbnails":["https://stockhead.com.au/wp-content/uploads/2024/11/2024-19-11-TYP-NM-1-640x360.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stockhead.com.au/health/tryptamines-world-first-psilocin-based-iv-infusion-meets-key-objectives-in-phase-1b-study/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockheads_stock","symbols":["PK","SRC","BK4181","BK4218","BK4080","BK4231"],"gpt_icon":0},{"id":"2484190783","title":"Pasithea Therapeutics announces SRC recommended proceeding to cohort 4","url":"https://stock-news.laohu8.com/highlight/detail?id=2484190783","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2484190783?lang=en_us&edition=fundamental","pubTime":"2024-11-20 20:25","pubTimestamp":1732105531,"startTime":"0","endTime":"0","summary":"Pasithea Therapeutics (KTTA) announced that the external Safety Review Committee, SRC, recommended proceeding to cohort 4, 15mg capsule, without mo...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/pasithea-therapeutics-announces-src-recommended-proceeding-to-cohort-4?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/pasithea-therapeutics-announces-src-recommended-proceeding-to-cohort-4?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4080","BK4231","SRC","BK4139","KTTA","LENZ"],"gpt_icon":0},{"id":"2484192072","title":"Pasithea Therapeutics Announces Positive Safety Review Committee (SRC) Recommendation from its ongoing Phase 1 Clinical Trial of PAS-004 in Advanced Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2484192072","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2484192072?lang=en_us&edition=fundamental","pubTime":"2024-11-20 20:02","pubTimestamp":1732104120,"startTime":"0","endTime":"0","summary":"-- SRC recommended that the trial escalate to the next dose level of 15mg capsule --. -- No dose-limiting toxicities  observed to date --. Dr. Tiago Reis Marques, Chief Executive Officer of Pasithea stated, “We are pleased to observe that as we continue to dose escalate, we have not yet seen rash emerge. Rash is a common adverse event  that is observed at low doses with competitor MEK inhibitors and may lead to the high discontinuation rate in real world practice. In addition, we are excited to dose patients with our potential commercial formulation.”Pasithea is a biotechnology company focused on the discovery, research and development of innovative treatments for central nervous system  disorders and RASopathies. With an experienced team of experts in the fields of neuroscience, translational medicine, and drug development, Pasithea is developing new molecular entities for the treatment of neurologi","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/gIokpGPCXewyfjJRBhDTxw--~B/aD0xNjE7dz0zMzg7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/73304d1b574477de471e2e9a4a8c2e2c","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/gIokpGPCXewyfjJRBhDTxw--~B/aD0xNjE7dz0zMzg7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/73304d1b574477de471e2e9a4a8c2e2c"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/pasithea-therapeutics-announces-positive-safety-120200893.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["PK","BK4135","LU1169590202.USD","AEIS","KTTA","BK4166","BK4563","BK4503","PD","IE0031619046.USD","KTTAW","BK4139","IE00B7SZL793.SGD","BK4157","CNS","QD","IE00B66KJ199.SGD","BK4023","BK4080","BK4231","AE","BK4181","SRC","BK4138","BK4218","IE00B19Z4B17.USD","LENZ","LU1169589451.USD"],"gpt_icon":1},{"id":"2481175598","title":"Deutsche Bank  Reaffirms Their Buy Rating on SigmaRoc (SRC)","url":"https://stock-news.laohu8.com/highlight/detail?id=2481175598","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481175598?lang=en_us&edition=fundamental","pubTime":"2024-11-08 19:50","pubTimestamp":1731066603,"startTime":"0","endTime":"0","summary":"In a report released today, Christen Hjorth from Deutsche Bank maintained a Buy rating on SigmaRoc (SRC – Research Report), with a price target of ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/deutsche-bank-reaffirms-their-buy-rating-on-sigmaroc-src?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/deutsche-bank-reaffirms-their-buy-rating-on-sigmaroc-src?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["DB","SRC"],"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":2,"totalSize":33,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/SRC\",params:#limit:5,,,undefined,":[{"market":"US","date":"2024-01-23","symbol":"SRC","reason":null,"defaultRemindTime":1706020200000,"announcedDate":"2024-01-10","type":"delisting","dateTimestamp":1705986000000},{"date":"2023-12-27","symbol":"SRC","amount":0.6696,"announcedDate":"2023-11-28","type":"dividend","market":"US","newRecordDate":"2023-12-28","defaultRemindTime":1703687400000,"name":"Spirit Realty Capital","recordDate":"2024-01-12","payableDate":"2023-12-28","currency":"USD","dateTimestamp":1703653200000,"payDate":"2024-01-12"},{"market":"US","date":"2023-11-02","symbol":"SRC","fiscalQuarterEnding":"2023/09","expectedEps":0.86,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1698897600000,"reportTimeType":"pre","actualEps":0.92},{"date":"2023-09-28","symbol":"SRC","amount":0.6696,"announcedDate":"2023-08-09","type":"dividend","market":"US","newRecordDate":"2023-09-29","defaultRemindTime":1695907800000,"name":"Spirit Realty Capital","recordDate":"2023-10-13","payableDate":"2023-09-29","currency":"USD","dateTimestamp":1695873600000,"payDate":"2023-10-13"},{"market":"US","date":"2023-08-07","symbol":"SRC","fiscalQuarterEnding":"2023/06","expectedEps":0.86,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1691380800000,"reportTimeType":"post","actualEps":0.91}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"SRC\",market:\"US\",,,undefined,":[{"executeDate":"2017-03-29","recordDate":"2017-03-31","paymentDate":"2017-04-14","value":0.18,"currency":"USD"},{"executeDate":"2017-06-28","recordDate":"2017-06-30","paymentDate":"2017-07-14","value":0.18,"currency":"USD"},{"executeDate":"2017-09-28","recordDate":"2017-09-29","paymentDate":"2017-10-13","value":0.18,"currency":"USD"},{"executeDate":"2017-12-28","recordDate":"2017-12-29","paymentDate":"2018-01-12","value":0.18,"currency":"USD"},{"executeDate":"2018-03-28","recordDate":"2018-03-30","paymentDate":"2018-04-13","value":0.18,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"SRC\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.1429,"buy":0.0714,"hold":0.7857,"sell":0,"strongSell":0,"meanLabel":"HOLD","meanPercent":0.7857,"analysts":14,"updateTime":1699678800000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/SRC\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"SRC","date":"2024-01-23","current":23.132655,"percent":0.299677,"low":11.974037,"twenty":21.77699,"median":25.699054,"eighty":47.920767,"high":2180.914394,"avg":155.68251,"sd":460.537211,"marketCap":5989090759},"quantilePoints":[{"date":"2020-05-08","current":26.54342,"twenty":-93.997436,"median":26.475166,"eighty":41.659269,"marketCap":3074816366},{"date":"2020-05-15","current":23.228825,"twenty":-93.810003,"median":26.475166,"eighty":41.659269,"marketCap":2690850345},{"date":"2020-05-22","current":25.29045,"twenty":-93.609189,"median":26.475166,"eighty":41.659269,"marketCap":2929671033},{"date":"2020-05-29","current":25.263791,"twenty":-93.35014,"median":26.481687,"eighty":41.659269,"marketCap":2926582835},{"date":"2020-06-05","current":33.19927,"twenty":-92.966557,"median":26.536805,"eighty":41.659269,"marketCap":3845836606},{"date":"2020-06-12","current":30.853283,"twenty":-92.87284,"median":26.61547,"eighty":41.659269,"marketCap":3574075133},{"date":"2020-06-19","current":31.750801,"twenty":-92.685408,"median":26.687479,"eighty":41.659269,"marketCap":3678044484},{"date":"2020-06-26","current":30.551148,"twenty":-92.055771,"median":26.771857,"eighty":41.659269,"marketCap":3539075549},{"date":"2020-07-02","current":30.435626,"twenty":-92.055771,"median":26.827299,"eighty":41.659269,"marketCap":3525693356},{"date":"2020-07-10","current":28.756113,"twenty":-91.748245,"median":26.880343,"eighty":41.659269,"marketCap":3331136846},{"date":"2020-07-17","current":30.382308,"twenty":-91.581806,"median":26.967004,"eighty":41.659269,"marketCap":3519516958},{"date":"2020-07-24","current":28.987157,"twenty":-91.172425,"median":27.000883,"eighty":41.659269,"marketCap":3357901234},{"date":"2020-07-31","current":50.951563,"twenty":-90.831904,"median":27.183235,"eighty":41.707972,"marketCap":3550865398},{"date":"2020-08-07","current":52.23792,"twenty":-90.248784,"median":27.464856,"eighty":41.920968,"marketCap":3640512899},{"date":"2020-08-14","current":52.903277,"twenty":-89.993422,"median":27.592346,"eighty":42.086263,"marketCap":3686882296},{"date":"2020-08-21","current":52.163992,"twenty":-89.613313,"median":27.902363,"eighty":42.245568,"marketCap":3635360744},{"date":"2020-08-28","current":53.731277,"twenty":-89.050887,"median":28.030598,"eighty":42.353314,"marketCap":3744586435},{"date":"2020-09-04","current":53.923491,"twenty":-88.287296,"median":28.249351,"eighty":42.410344,"marketCap":3757982039},{"date":"2020-09-11","current":53.524277,"twenty":-88.154584,"median":28.460561,"eighty":42.475124,"marketCap":3730160401},{"date":"2020-09-18","current":52.784992,"twenty":-88.001027,"median":28.746196,"eighty":42.534926,"marketCap":3678638848},{"date":"2020-09-25","current":50.315778,"twenty":-87.024944,"median":28.859221,"eighty":42.725691,"marketCap":3506556863},{"date":"2020-10-02","current":52.784992,"twenty":-86.762538,"median":29.064019,"eighty":42.777357,"marketCap":3678638848},{"date":"2020-10-09","current":51.321206,"twenty":13.104171,"median":29.31595,"eighty":42.859575,"marketCap":3576626174},{"date":"2020-10-16","current":47.979635,"twenty":14.494025,"median":29.546785,"eighty":42.940728,"marketCap":3343748757},{"date":"2020-10-23","current":49.768706,"twenty":15.048563,"median":29.688076,"eighty":43.018204,"marketCap":3468430914},{"date":"2020-10-30","current":44.431064,"twenty":15.276158,"median":29.871143,"eighty":43.068933,"marketCap":3096445305},{"date":"2020-11-06","current":1514.980316,"twenty":15.709562,"median":30.009083,"eighty":43.17951,"marketCap":3325381794},{"date":"2020-11-13","current":1803.901979,"twenty":16.645311,"median":30.127612,"eighty":43.263013,"marketCap":3959564845},{"date":"2020-11-20","current":1764.255782,"twenty":17.947113,"median":30.382308,"eighty":43.333315,"marketCap":3872541442},{"date":"2020-11-27","current":1871.300515,"twenty":21.225642,"median":30.527403,"eighty":43.417649,"marketCap":4107504631},{"date":"2020-12-04","current":2036.214107,"twenty":21.623279,"median":30.791079,"eighty":43.486526,"marketCap":4469489965},{"date":"2020-12-11","current":2090.867093,"twenty":21.778606,"median":30.951032,"eighty":43.62088,"marketCap":4589453270},{"date":"2020-12-18","current":2091.387598,"twenty":21.870027,"median":31.395348,"eighty":43.74382,"marketCap":4590595777},{"date":"2020-12-24","current":2097.113149,"twenty":21.936595,"median":31.875209,"eighty":43.806946,"marketCap":4603163362},{"date":"2020-12-31","current":2090.867093,"twenty":22.059969,"median":32.941567,"eighty":43.929815,"marketCap":4589453270},{"date":"2021-01-08","current":2003.422316,"twenty":22.346658,"median":34.450941,"eighty":43.978577,"marketCap":4397511983},{"date":"2021-01-15","current":1987.286672,"twenty":22.499322,"median":35.307705,"eighty":44.086589,"marketCap":4362094245},{"date":"2021-01-22","current":2066.403376,"twenty":22.706129,"median":35.84882,"eighty":44.134242,"marketCap":4535755410},{"date":"2021-01-29","current":2007.065848,"twenty":22.853468,"median":36.261669,"eighty":44.247898,"marketCap":4405509536},{"date":"2021-02-05","current":2086.182552,"twenty":23.100216,"median":36.657717,"eighty":44.326702,"marketCap":4579170701},{"date":"2021-02-12","current":2145.520079,"twenty":23.286608,"median":36.79577,"eighty":44.366344,"marketCap":4709416574},{"date":"2021-02-19","current":184.197094,"twenty":23.35939,"median":36.931048,"eighty":44.406964,"marketCap":4919535990},{"date":"2021-02-26","current":185.014219,"twenty":23.466787,"median":37.055826,"eighty":44.537229,"marketCap":4941359755},{"date":"2021-03-05","current":178.864281,"twenty":23.544894,"median":37.12062,"eighty":44.646862,"marketCap":4777107211},{"date":"2021-03-12","current":184.326114,"twenty":23.649571,"median":37.201605,"eighty":44.741227,"marketCap":4922981848},{"date":"2021-03-19","current":179.896438,"twenty":23.76334,"median":37.267154,"eighty":45.068895,"marketCap":4804674071},{"date":"2021-03-26","current":185.659317,"twenty":23.855579,"median":37.309462,"eighty":45.145403,"marketCap":4958589043},{"date":"2021-04-01","current":186.863501,"twenty":23.974367,"median":37.362574,"eighty":45.33813,"marketCap":4990750380},{"date":"2021-04-09","current":188.669776,"twenty":24.033695,"median":37.482017,"eighty":45.49559,"marketCap":5038992386},{"date":"2021-04-16","current":190.734091,"twenty":24.170556,"median":37.517255,"eighty":45.728304,"marketCap":5094126107},{"date":"2021-04-23","current":197.787167,"twenty":24.300666,"median":37.561888,"eighty":46.08352,"marketCap":5282499654},{"date":"2021-04-30","current":204.453184,"twenty":24.376499,"median":37.577713,"eighty":46.298453,"marketCap":5460535629},{"date":"2021-05-07","current":132.237039,"twenty":24.536847,"median":37.652534,"eighty":46.41481,"marketCap":5433090981},{"date":"2021-05-14","current":128.487618,"twenty":24.584413,"median":37.71081,"eighty":46.484624,"marketCap":5279042274},{"date":"2021-05-21","current":128.925556,"twenty":24.636739,"median":37.832905,"eighty":46.787152,"marketCap":5297035392},{"date":"2021-05-28","current":132.227035,"twenty":24.751207,"median":37.867956,"eighty":46.996595,"marketCap":5432679961},{"date":"2021-06-04","current":138.438292,"twenty":24.770977,"median":37.888273,"eighty":47.920492,"marketCap":5687875677},{"date":"2021-06-11","current":142.355301,"twenty":24.827339,"median":37.94667,"eighty":48.902994,"marketCap":5848809912},{"date":"2021-06-18","current":133.430116,"twenty":24.902133,"median":37.998298,"eighty":49.593837,"marketCap":5482109762},{"date":"2021-06-25","current":136.675638,"twenty":24.963422,"median":38.049927,"eighty":49.839678,"marketCap":5615455271},{"date":"2021-07-02","current":134.269475,"twenty":25.019346,"median":38.05837,"eighty":50.279896,"marketCap":5516595669},{"date":"2021-07-09","current":136.283937,"twenty":25.087824,"median":38.065735,"eighty":51.223621,"marketCap":5599361847},{"date":"2021-07-16","current":135.696386,"twenty":25.161407,"median":38.153183,"eighty":51.578478,"marketCap":5575221712},{"date":"2021-07-23","current":139.949139,"twenty":25.274023,"median":38.238741,"eighty":51.995435,"marketCap":5749950310},{"date":"2021-07-30","current":140.508711,"twenty":25.379375,"median":38.256439,"eighty":52.492234,"marketCap":5772940915},{"date":"2021-08-06","current":47.126902,"twenty":25.419415,"median":38.331929,"eighty":52.634177,"marketCap":6099304983},{"date":"2021-08-13","current":46.841619,"twenty":25.506579,"median":38.393809,"eighty":52.601649,"marketCap":6062382809},{"date":"2021-08-20","current":45.580852,"twenty":25.567588,"median":38.428701,"eighty":52.601649,"marketCap":5899210619},{"date":"2021-08-27","current":46.952051,"twenty":25.682178,"median":38.565058,"eighty":52.601649,"marketCap":6076675263},{"date":"2021-09-03","current":47.8079,"twenty":25.731746,"median":38.769257,"eighty":52.601649,"marketCap":6187441786},{"date":"2021-09-10","current":45.507231,"twenty":25.767762,"median":38.841996,"eighty":52.601649,"marketCap":5889682316},{"date":"2021-09-17","current":45.442812,"twenty":25.854339,"median":38.921369,"eighty":52.601649,"marketCap":5881345051},{"date":"2021-09-24","current":44.991881,"twenty":25.875526,"median":39.185745,"eighty":52.601649,"marketCap":5822984195},{"date":"2021-10-01","current":43.61148,"twenty":25.926473,"median":39.318072,"eighty":52.601649,"marketCap":5644328513},{"date":"2021-10-08","current":43.445831,"twenty":25.936015,"median":39.366062,"eighty":52.480406,"marketCap":5622889831},{"date":"2021-10-15","current":44.264869,"twenty":25.941955,"median":39.542896,"eighty":52.368034,"marketCap":5728892202},{"date":"2021-10-22","current":44.807827,"twenty":25.946911,"median":39.59877,"eighty":52.246792,"marketCap":5799163437},{"date":"2021-10-29","current":45.028692,"twenty":25.95304,"median":39.779469,"eighty":52.208349,"marketCap":5827748346},{"date":"2021-11-05","current":38.774704,"twenty":25.955541,"median":39.584452,"eighty":52.193563,"marketCap":6068357526},{"date":"2021-11-12","current":38.112832,"twenty":25.955541,"median":39.34367,"eighty":52.193563,"marketCap":5964772476},{"date":"2021-11-19","current":36.891519,"twenty":25.955541,"median":39.185745,"eighty":52.193563,"marketCap":5773633395},{"date":"2021-11-26","current":35.851433,"twenty":25.955541,"median":39.121399,"eighty":52.193563,"marketCap":5610856888},{"date":"2021-12-03","current":35.236837,"twenty":25.955541,"median":38.915134,"eighty":52.193563,"marketCap":5514670769},{"date":"2021-12-10","current":37.072746,"twenty":25.955541,"median":38.813951,"eighty":52.193563,"marketCap":5801995968},{"date":"2021-12-17","current":36.300561,"twenty":25.955541,"median":38.721092,"eighty":52.193563,"marketCap":5681146743},{"date":"2021-12-23","current":37.143661,"twenty":25.955541,"median":38.621326,"eighty":52.193563,"marketCap":5813094367},{"date":"2021-12-31","current":37.971002,"twenty":25.955541,"median":38.465026,"eighty":52.193563,"marketCap":5942575679},{"date":"2022-01-07","current":37.986761,"twenty":25.958043,"median":38.424681,"eighty":52.178778,"marketCap":5945041990},{"date":"2022-01-14","current":40.479343,"twenty":25.958043,"median":38.411323,"eighty":52.178778,"marketCap":6335138658},{"date":"2022-01-21","current":37.231857,"twenty":25.958043,"median":38.390333,"eighty":52.178778,"marketCap":5826897339},{"date":"2022-01-28","current":38.251796,"twenty":25.958043,"median":38.332389,"eighty":52.178778,"marketCap":5986520869},{"date":"2022-02-04","current":37.01971,"twenty":25.958043,"median":38.318497,"eighty":52.178778,"marketCap":5793695644},{"date":"2022-02-11","current":37.501121,"twenty":25.958043,"median":38.254117,"eighty":52.178778,"marketCap":5869037951},{"date":"2022-02-18","current":34.819069,"twenty":25.958043,"median":38.240969,"eighty":52.178778,"marketCap":5978503814},{"date":"2022-02-25","current":34.804189,"twenty":25.958043,"median":38.215079,"eighty":52.178778,"marketCap":5975948898},{"date":"2022-03-04","current":35.272907,"twenty":25.958043,"median":38.146473,"eighty":52.178778,"marketCap":6056428757},{"date":"2022-03-11","current":34.56611,"twenty":25.958043,"median":38.085254,"eighty":52.178778,"marketCap":5935070239},{"date":"2022-03-18","current":34.335471,"twenty":25.958043,"median":38.065735,"eighty":52.178778,"marketCap":5895469039},{"date":"2022-03-25","current":34.208991,"twenty":25.958043,"median":38.049927,"eighty":52.178778,"marketCap":5873752251},{"date":"2022-04-01","current":34.819069,"twenty":25.958043,"median":38.027704,"eighty":52.178778,"marketCap":5978503814},{"date":"2022-04-08","current":34.157274,"twenty":25.958043,"median":37.977004,"eighty":52.178778,"marketCap":5864872207},{"date":"2022-04-14","current":34.231674,"twenty":25.958043,"median":37.947139,"eighty":52.178778,"marketCap":5877646923},{"date":"2022-04-22","current":34.291195,"twenty":25.958043,"median":37.91384,"eighty":52.178778,"marketCap":5887866696},{"date":"2022-04-29","current":32.327021,"twenty":25.958043,"median":37.872977,"eighty":52.178778,"marketCap":5550614188},{"date":"2022-05-06","current":24.292186,"twenty":25.931441,"median":37.847879,"eighty":52.178778,"marketCap":5568424854},{"date":"2022-05-13","current":24.6203,"twenty":25.875816,"median":37.793325,"eighty":52.178778,"marketCap":5643637539},{"date":"2022-05-20","current":23.805873,"twenty":25.858744,"median":37.793325,"eighty":52.178778,"marketCap":5456948910},{"date":"2022-05-27","current":24.678892,"twenty":25.770173,"median":37.782901,"eighty":52.178778,"marketCap":5657068375},{"date":"2022-06-03","current":24.380074,"twenty":25.738237,"median":37.748948,"eighty":52.178778,"marketCap":5588571109},{"date":"2022-06-10","current":23.173081,"twenty":25.689411,"median":37.691197,"eighty":52.178778,"marketCap":5311895875},{"date":"2022-06-17","current":21.632115,"twenty":25.601375,"median":37.652534,"eighty":52.178778,"marketCap":4958664872},{"date":"2022-06-24","current":22.53443,"twenty":25.542353,"median":37.577713,"eighty":52.193563,"marketCap":5165499756},{"date":"2022-07-01","current":22.809812,"twenty":25.47244,"median":37.561888,"eighty":52.193563,"marketCap":5228624688},{"date":"2022-07-08","current":23.290265,"twenty":25.403817,"median":37.533347,"eighty":52.193563,"marketCap":5338757548},{"date":"2022-07-15","current":24.239453,"twenty":25.337902,"median":37.509281,"eighty":52.193563,"marketCap":5556337101},{"date":"2022-07-22","current":25.083176,"twenty":25.254824,"median":37.472162,"eighty":52.193563,"marketCap":5749741148},{"date":"2022-07-29","current":25.979631,"twenty":25.187885,"median":37.336884,"eighty":52.193563,"marketCap":5955232948},{"date":"2022-08-05","current":25.912119,"twenty":25.170969,"median":37.272951,"eighty":52.193563,"marketCap":5805428947},{"date":"2022-08-12","current":27.220505,"twenty":25.170969,"median":37.246094,"eighty":52.193563,"marketCap":6098563570},{"date":"2022-08-19","current":25.97906,"twenty":25.170969,"median":37.201605,"eighty":52.193563,"marketCap":5820426532},{"date":"2022-08-26","current":25.516561,"twenty":25.170969,"median":37.156512,"eighty":52.193563,"marketCap":5716806852},{"date":"2022-09-02","current":24.439425,"twenty":25.137956,"median":37.11142,"eighty":52.193563,"marketCap":5475482069},{"date":"2022-09-09","current":25.321824,"twenty":25.093166,"median":37.072746,"eighty":52.193563,"marketCap":5673177512},{"date":"2022-09-16","current":25.638271,"twenty":25.087615,"median":37.021234,"eighty":52.193563,"marketCap":5744075189},{"date":"2022-09-23","current":23.331861,"twenty":25.064167,"median":36.930916,"eighty":52.193563,"marketCap":5227340202},{"date":"2022-09-30","current":22.005219,"twenty":25.007629,"median":36.79577,"eighty":52.193563,"marketCap":4930115329},{"date":"2022-10-07","current":21.518378,"twenty":24.962383,"median":36.660491,"eighty":52.193563,"marketCap":4821041981},{"date":"2022-10-14","current":21.475779,"twenty":24.922679,"median":36.48012,"eighty":52.193563,"marketCap":4811498063},{"date":"2022-10-21","current":21.512293,"twenty":24.858503,"median":36.221767,"eighty":52.193563,"marketCap":4819678564},{"date":"2022-10-28","current":23.362289,"twenty":24.827339,"median":35.972732,"eighty":52.193563,"marketCap":5234157287},{"date":"2022-11-04","current":23.25275,"twenty":24.773188,"median":35.585763,"eighty":52.193563,"marketCap":5209615783},{"date":"2022-11-11","current":21.599078,"twenty":24.752915,"median":35.307705,"eighty":52.193563,"marketCap":5611548483},{"date":"2022-11-18","current":22.13126,"twenty":24.730614,"median":35.1468,"eighty":52.193563,"marketCap":5749812121},{"date":"2022-11-25","current":22.389288,"twenty":24.643741,"median":34.819069,"eighty":52.193563,"marketCap":5816849037},{"date":"2022-12-02","current":22.174265,"twenty":24.613224,"median":34.65539,"eighty":52.193563,"marketCap":5760984941},{"date":"2022-12-09","current":22.195767,"twenty":24.573379,"median":34.541127,"eighty":52.193563,"marketCap":5766571350},{"date":"2022-12-16","current":21.867857,"twenty":24.543146,"median":34.417376,"eighty":52.193563,"marketCap":5681378603},{"date":"2022-12-23","current":21.916237,"twenty":24.446405,"median":34.275951,"eighty":52.193563,"marketCap":5693948025},{"date":"2022-12-30","current":21.464689,"twenty":24.380422,"median":34.231674,"eighty":52.193563,"marketCap":5576633423},{"date":"2023-01-06","current":21.760345,"twenty":24.359795,"median":34.142394,"eighty":51.862363,"marketCap":5653446555},{"date":"2023-01-13","current":22.684945,"twenty":24.292288,"median":34.037872,"eighty":51.436535,"marketCap":5893662170},{"date":"2023-01-20","current":22.201143,"twenty":24.227194,"median":33.993593,"eighty":50.924949,"marketCap":5767967953},{"date":"2023-01-27","current":23.05586,"twenty":24.158963,"median":33.821312,"eighty":49.833763,"marketCap":5990027736},{"date":"2023-02-03","current":23.319264,"twenty":24.035772,"median":33.569154,"eighty":49.526221,"marketCap":6058461254},{"date":"2023-02-10","current":23.668676,"twenty":23.978638,"median":33.003771,"eighty":48.325621,"marketCap":6149240411},{"date":"2023-02-17","current":23.760061,"twenty":23.932079,"median":31.884095,"eighty":47.733513,"marketCap":6172982652},{"date":"2023-02-24","current":22.87309,"twenty":23.84205,"median":31.670824,"eighty":47.598078,"marketCap":5942543254},{"date":"2023-03-03","current":20.736687,"twenty":23.798842,"median":30.977691,"eighty":47.598078,"marketCap":5920655868},{"date":"2023-03-10","current":19.479618,"twenty":23.754148,"median":30.853283,"eighty":47.598078,"marketCap":5561742600},{"date":"2023-03-17","current":19.167825,"twenty":23.71176,"median":30.554606,"eighty":47.598078,"marketCap":5472720806},{"date":"2023-03-24","current":18.895563,"twenty":23.637539,"median":30.435626,"eighty":47.598078,"marketCap":5394985612},{"date":"2023-03-31","current":19.717109,"twenty":23.607162,"median":30.200139,"eighty":47.583354,"marketCap":5629550204},{"date":"2023-04-06","current":19.197457,"twenty":23.544654,"median":30.039518,"eighty":47.583354,"marketCap":5481181035},{"date":"2023-04-14","current":18.984646,"twenty":23.490752,"median":29.961662,"eighty":47.598078,"marketCap":5420420327},{"date":"2023-04-21","current":18.776785,"twenty":23.446835,"median":29.795711,"eighty":47.598078,"marketCap":5361072659},{"date":"2023-04-28","current":18.658008,"twenty":23.389146,"median":29.57505,"eighty":47.598078,"marketCap":5327159706},{"date":"2023-05-05","current":16.805477,"twenty":23.336129,"median":29.387041,"eighty":47.598078,"marketCap":5472417898},{"date":"2023-05-12","current":16.68832,"twenty":23.314814,"median":29.262633,"eighty":47.627527,"marketCap":5434267812},{"date":"2023-05-19","current":16.666625,"twenty":23.281907,"median":28.987157,"eighty":47.627527,"marketCap":5427202982},{"date":"2023-05-26","current":16.414955,"twenty":23.207241,"median":28.852809,"eighty":47.627527,"marketCap":5345250945},{"date":"2023-06-02","current":16.74039,"twenty":23.145644,"median":28.73834,"eighty":47.627527,"marketCap":5451223406},{"date":"2023-06-09","current":17.248069,"twenty":23.092708,"median":28.45223,"eighty":47.627527,"marketCap":5616540446},{"date":"2023-06-16","current":17.369565,"twenty":22.98083,"median":28.181067,"eighty":47.627527,"marketCap":5656103498},{"date":"2023-06-22","current":16.93999,"twenty":22.950432,"median":28.000425,"eighty":47.642251,"marketCap":5516219849},{"date":"2023-06-30","current":17.04413,"twenty":22.860626,"median":27.902363,"eighty":47.658919,"marketCap":5550131037},{"date":"2023-07-07","current":17.096199,"twenty":22.819497,"median":27.713783,"eighty":47.667253,"marketCap":5567086631},{"date":"2023-07-14","current":17.690661,"twenty":22.781974,"median":27.511978,"eighty":47.675587,"marketCap":5760662993},{"date":"2023-07-19","current":17.786122,"twenty":22.720474,"median":27.355963,"eighty":47.675587,"marketCap":5791748248},{"date":"2023-07-28","current":17.573504,"twenty":22.679408,"median":27.156228,"eighty":47.708717,"marketCap":5722512907},{"date":"2023-08-04","current":16.987721,"twenty":22.594109,"median":27.00691,"eighty":47.708717,"marketCap":5531762477},{"date":"2023-08-11","current":18.910849,"twenty":22.487052,"median":26.968876,"eighty":47.708717,"marketCap":5617921480},{"date":"2023-08-18","current":17.992662,"twenty":22.38232,"median":26.902938,"eighty":47.708717,"marketCap":5345151959},{"date":"2023-08-25","current":18.268594,"twenty":22.358559,"median":26.838753,"eighty":47.708717,"marketCap":5427124147},{"date":"2023-09-01","current":18.3685,"twenty":22.31833,"median":26.767597,"eighty":47.708717,"marketCap":5456803732},{"date":"2023-09-08","current":17.88324,"twenty":22.243073,"median":26.695235,"eighty":47.708717,"marketCap":5312645747},{"date":"2023-09-15","current":17.559734,"twenty":22.194692,"median":26.633237,"eighty":47.708717,"marketCap":5216540423},{"date":"2023-09-22","current":16.76524,"twenty":22.132664,"median":26.581405,"eighty":47.708717,"marketCap":4980517055},{"date":"2023-09-29","current":15.842296,"twenty":22.071204,"median":26.533855,"eighty":47.733513,"marketCap":4706334221},{"date":"2023-10-06","current":15.699573,"twenty":22.00403,"median":26.476535,"eighty":47.733513,"marketCap":4663934814},{"date":"2023-10-13","current":15.985019,"twenty":21.941181,"median":26.439984,"eighty":47.733513,"marketCap":4748733628},{"date":"2023-10-20","current":15.875598,"twenty":21.917751,"median":26.407224,"eighty":47.758308,"marketCap":4716227416},{"date":"2023-10-27","current":15.74239,"twenty":21.883916,"median":26.38613,"eighty":47.822624,"marketCap":4676654636},{"date":"2023-11-03","current":20.803751,"twenty":21.866782,"median":26.2991,"eighty":47.822624,"marketCap":5386132717},{"date":"2023-11-10","current":20.863798,"twenty":21.816731,"median":26.240737,"eighty":47.822624,"marketCap":5401679151},{"date":"2023-11-17","current":22.031997,"twenty":21.780722,"median":26.064257,"eighty":47.822624,"marketCap":5704127958},{"date":"2023-11-24","current":22.359529,"twenty":21.780722,"median":25.985145,"eighty":47.822624,"marketCap":5788926689},{"date":"2023-12-01","current":22.54513,"twenty":21.780722,"median":25.946161,"eighty":47.822624,"marketCap":5836979303},{"date":"2023-12-07","current":22.927251,"twenty":21.780555,"median":25.927715,"eighty":47.837348,"marketCap":5935911156},{"date":"2023-12-14","current":23.669657,"twenty":21.780389,"median":25.885891,"eighty":47.852073,"marketCap":6128121612},{"date":"2023-12-22","current":23.838882,"twenty":21.780222,"median":25.864321,"eighty":47.866797,"marketCap":6171934290},{"date":"2023-12-29","current":24.253756,"twenty":21.780055,"median":25.813567,"eighty":47.881521,"marketCap":6279346015},{"date":"2024-01-05","current":23.964436,"twenty":21.778523,"median":25.768364,"eighty":47.901144,"marketCap":6204440470},{"date":"2024-01-12","current":24.646795,"twenty":21.778523,"median":25.744647,"eighty":47.901144,"marketCap":6381104492},{"date":"2024-01-19","current":23.314831,"twenty":21.77699,"median":25.711108,"eighty":47.920767,"marketCap":6036256320},{"date":"2024-01-23","current":23.132655,"twenty":21.77699,"median":25.699054,"eighty":47.920767,"marketCap":5989090759}],"updateTime":1746708270024}}}